Contact this trialFirst, we need to learn more about you.
VEGF Inhibitor
Cabozantinib + Dostarlimab for Gynecologic Cancers
Recruiting1 awardPhase 1 & 2
Birmingham, Alabama
This trial will test whether combining a VEGF inhibitor with immunotherapy will be more effective in treating gynecologic cancers than either treatment alone.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.